THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 122 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $160,838 | -7.9% | 18,637 | +10.5% | 0.00% | – |
Q2 2023 | $174,636 | -7.7% | 16,873 | -3.3% | 0.00% | – |
Q1 2023 | $189,256 | -9.1% | 17,443 | -6.0% | 0.00% | – |
Q4 2022 | $208,187 | +15.7% | 18,555 | +4.7% | 0.00% | – |
Q3 2022 | $180,000 | +12.5% | 17,726 | +0.3% | 0.00% | – |
Q2 2022 | $160,000 | +58.4% | 17,674 | +67.9% | 0.00% | – |
Q1 2022 | $101,000 | -45.1% | 10,525 | -57.6% | 0.00% | – |
Q3 2021 | $184,000 | -14.8% | 24,799 | +67.0% | 0.00% | – |
Q2 2021 | $216,000 | -25.0% | 14,850 | +5.2% | 0.00% | – |
Q1 2021 | $288,000 | -31.8% | 14,110 | -40.7% | 0.00% | – |
Q4 2020 | $422,000 | +146.8% | 23,776 | +105.8% | 0.00% | – |
Q3 2020 | $171,000 | -32.9% | 11,554 | -4.7% | 0.00% | – |
Q2 2020 | $255,000 | +27.5% | 12,126 | +40.3% | 0.00% | – |
Q1 2020 | $200,000 | -6.5% | 8,640 | +4.5% | 0.00% | – |
Q4 2019 | $214,000 | +5.9% | 8,267 | +4.6% | 0.00% | – |
Q4 2018 | $202,000 | -57.7% | 7,907 | -46.0% | 0.00% | – |
Q3 2018 | $478,000 | +103.4% | 14,632 | +51.3% | 0.00% | – |
Q1 2018 | $235,000 | -4.5% | 9,674 | +9.9% | 0.00% | – |
Q4 2017 | $246,000 | -16.3% | 8,806 | +2.7% | 0.00% | – |
Q3 2017 | $294,000 | -48.5% | 8,572 | -40.2% | 0.00% | -100.0% |
Q2 2017 | $571,000 | +36.0% | 14,329 | +25.7% | 0.00% | 0.0% |
Q1 2017 | $420,000 | – | 11,398 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 7,269,584 | $69,497,223,000 | 12.98% |
Newtyn Management, LLC | 1,375,000 | $13,145,000 | 3.15% |
Chescapmanager LLC | 1,166,574 | $11,152,000 | 1.51% |
Baupost Group | 13,643,333 | $130,430,000 | 1.40% |
Weiss Asset Management LP | 5,412,487 | $51,743,000 | 1.07% |
CM Management, LLC | 120,000 | $1,147,000 | 0.96% |
Orbimed Advisors | 3,254,713 | $31,115,000 | 0.50% |
King Wealth Management Group | 122,000 | $1,166,000 | 0.23% |
Woodline Partners LP | 1,326,653 | $12,683,000 | 0.21% |
PDT Partners, LLC | 192,701 | $1,842,000 | 0.16% |